MedBlog

David Sher, M.D.

DARTBOARD: Novel head & neck cancer trial targets personalized, daily radiation therapy

David Sher, M.D. explains how a new clinical trial for head and neck cancer patients will study daily adaptive radiotherapy using tumor targeting driven by an AI-driven algorithm developed by UT Southwestern.

David Sher, M.D.

March 2, 2022